<DOC>
	<DOC>NCT01089218</DOC>
	<brief_summary>Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.</brief_summary>
	<brief_title>The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines</brief_title>
	<detailed_description>For the population being undergone with bronchoscopy, the clinical signs and procedural measures for complication of bronchoscopy and cytokines will be checked.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>adult patients (aged 18 years or older) who underwent FB concurrent treatment with antibiotics or systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>bronchoscopy</keyword>
	<keyword>post-bronchoscopy fever</keyword>
	<keyword>pneumonia</keyword>
	<keyword>cytokines</keyword>
	<keyword>amoxicillin/clavulanate</keyword>
	<keyword>prophylaxis</keyword>
</DOC>